These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2754289

  • 1. [The clinical usefulness of serum CA72-4 analysis in patients with ovarian cancer].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):585-9. PubMed ID: 2754289
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
    Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
    [Abstract] [Full Text] [Related]

  • 3. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G.
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [Abstract] [Full Text] [Related]

  • 4. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
    Nozawa S, Udagawa Y, Ito K, Susumu N, Sasaki H, Aoki D.
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
    [Abstract] [Full Text] [Related]

  • 5. [Primary research on saliva and serum CA125 assays for detecting malignant ovarian tumors].
    Chen DX, Li FQ.
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):84-5, 123-4. PubMed ID: 2364796
    [Abstract] [Full Text] [Related]

  • 6. [Clinical value of a new serum tumor marker CA602 in ovarian cancers].
    Suzuki M, Sekiguchi I, Ohwada M, Aida I, Tamada T.
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul 20; 25(7):1454-60. PubMed ID: 2170549
    [Abstract] [Full Text] [Related]

  • 7. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K, Kikkawa F, Shibata K, Tomoda K, Obata NH, Wakahara F, Tokuhashi Y, Ishikawa H, Kawai M, Tomoda Y.
    Gynecol Oncol; 1996 Jul 20; 62(1):67-72. PubMed ID: 8690294
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis of ovarian tumor by measuring tumor markers].
    Fukatsu T, Nakashima N, Takeuchi J.
    Rinsho Byori; 1992 Feb 20; 40(2):133-8. PubMed ID: 1583785
    [Abstract] [Full Text] [Related]

  • 9. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H, Sawaguchi K, Hieda S, Ogawa A, Tomatsu A, Noguchi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb 20; 41(2):217-24. PubMed ID: 2566639
    [Abstract] [Full Text] [Related]

  • 10. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes].
    Nozawa S, Yajima M, Udagawa Y, Kiguchi K, Iizuka R, Kimura E, Terashima Y, Inaba N, Takamizawa H, Negishi Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov 20; 41(11):1823-9. PubMed ID: 2687409
    [Abstract] [Full Text] [Related]

  • 11. [Application of monoclonal antibody OC 125 in gynecological oncology].
    Wu AR, Wang EY, Wang XX, Jia XH, Li L.
    Zhonghua Zhong Liu Za Zhi; 1988 Mar 20; 10(2):132-6. PubMed ID: 3208653
    [Abstract] [Full Text] [Related]

  • 12. CA54/61 as a marker for epithelial ovarian cancer.
    Nozawa S, Aoki D, Yajima M, Tsukazaki K, Kobayashi T, Kimura E, Terashima Y, Inaba N, Takamizawa H, Negishi Y.
    Cancer Res; 1992 Mar 01; 52(5):1205-9. PubMed ID: 1737381
    [Abstract] [Full Text] [Related]

  • 13. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E, Murae M, Koga R, Odawara Y, Nakabayashi Y, Yokoyama K, Nakata H, Totake T, Ochiai K, Yasuda M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov 01; 36(11):2121-8. PubMed ID: 6595320
    [Abstract] [Full Text] [Related]

  • 14. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M, Ogawa H, Nakanishi K, Tanizawa O, Karino K, Endo J.
    Obstet Gynecol; 1990 Jun 01; 75(6):1032-6. PubMed ID: 2342728
    [Abstract] [Full Text] [Related]

  • 15. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
    Oishi T, Maruo T, Iwasaki M, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep 01; 38(9):1595-604. PubMed ID: 3464659
    [Abstract] [Full Text] [Related]

  • 16. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
    Stratton JA, Rettenmaier MA, Phillips HB, Herabutya S, DiSaia PJ.
    Obstet Gynecol; 1988 Jan 01; 71(1):20-6. PubMed ID: 2827081
    [Abstract] [Full Text] [Related]

  • 17. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
    Kobayashi H, Kawashima Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov 01; 41(11):1731-5. PubMed ID: 2574209
    [Abstract] [Full Text] [Related]

  • 18. [The clinical usefulness of the measurement of serum sialyl SSEA-1 antigen levels in patients with gynecologic diseases: as respects the comparative effectiveness of sialyl SSEA-1 and CA125].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul 01; 40(7):828-34. PubMed ID: 3166483
    [Abstract] [Full Text] [Related]

  • 19. [Diagnostic usefulness of stepwise discriminant analysis employing the values of CA125, TPA, IAP, CEA and ferritin in sera measured simultaneously for gynecological malignant neoplasms].
    Yabushita H, Masuda T, Hattori A, Noguchi M, Ito Y, Nakanishi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Sep 01; 37(9):1883-92. PubMed ID: 2997349
    [Abstract] [Full Text] [Related]

  • 20. [Serum CA125 in malignant ovarian tumor--periodical monitoring and correlation with other tumor markers].
    Kawai M, Yamashita H, Hayashi T, Kamiya N, Kakihara M, Arii Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Mar 01; 38(3):402-10. PubMed ID: 3457877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.